Bausch + Lomb Corporation (BLCO)
NYSE · Manufacturing · Ophthalmic goods
BLCO price, last 12 months
Key stats
- Previous close
- $20.95
- Open
- $20.84
- Day range
- $20.57 – $21.07
- 52-week range
- $14.44 – $21.40
- Volume
- 398.1K
- Avg volume (20 days)
- 1.1M
- Market cap
- $7.5B
Performance
Technicals and fundamentals
About Bausch + Lomb Corporation
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes brands like Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, and surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xiidra and Miebo that treat various eye complications.
- Sector
- Manufacturing
- Industry
- Ophthalmic goods
- Listed on
- NYSE
- Market cap
- $7.5B